2.410PLN+4.33%Mkt Cap: 102.74M PLNP/E: —Last update: 2026-06-01
NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap102.74M PLN
Enterprise Value86.89M PLN
Revenue (TTM)8.00K PLN
Gross Profit-44.46K PLN
Net Income (TTM)-5.17M PLN
Revenue/Share—
Last Price2.410 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLNNGRP00011
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-8.96
EV/Revenue10861.87
P/S12309.12
P/B6.88
EPS (TTM)-0.19
EPS (Forward)—
52W Range
2.25017% of range3.200
52W High3.200 PLN
52W Low2.250 PLN
Profitability
Gross Margin-2117.10%
Oper. Margin-28412.50%
EBITDA Margin0.00%
Profit Margin-246079.19%
ROE-34.00%
ROA-25.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.72M PLN
CapEx (TTM)3.28M PLN
FCF Margin-63815.22%
FCF Yield-4.97%
Net Debt-12.10M PLN
Net Debt/EBITDA1.25
Balance Sheet
Debt/Equity0.00
Current Ratio11.43
Quick Ratio10.65
Book Value/Sh0.3360 PLN
Cash/Share0.2840 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.63M
Float29.16M
Insiders20.25%
Institutions0.00%
Technical
SMA 502.469 (-2.4%)
SMA 2002.606 (-7.5%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)56.60K
Avg Vol (10d)34.60K
Technical Indicators
RSI (14)36.4
MACD-0.0515
MACD Signal-0.0450
MACD Hist.-0.0064
BB Upper2.549 PLN
BB Middle2.395 PLN
BB Lower2.241 PLN
BB Width12.83%
ATR (14)0.0814 PLN
Vol Ratio (20d)1.18x